hotspot -WSS

hotspot

author：explore 2025-09-30 00:38:10 - browse：82949

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Elizabeth Warren probes abortion access

WSS

What to know about Saharan dust affecting the US and how it can affect health

Live blog: Hearing on CRISPR

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Court strikes down limits on filming of police in Arizona

What is microchimerism and how does it affect maternal health?

Body of missing toddler recovered in Delaware River days after flood: Police

knowledge

hotspot

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Bill would allow buprenorphine prescription for addiction via telehealth

Sports medicine is finally prioritizing gender equality

Russian special forces kill a gunman who broke into a private house near Moscow

ChatGPT in medicine: STAT answers readers' burning questions

What is microchimerism and how does it affect maternal health?

After affirmative action ruling, medical educators look to 'holistic review'

Review: 'Barbie' will hit you like a shot in the heart

Drug repurposing or repositioning? The language matters

Medicare proceeds with plan to claw back hospital funds

hotspot

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Providers still hesitate to prescribe buprenorphine, study finds

Why an extreme heat and wildfire smoke combination can be so dangerous

Kidney transplant patients stopped immunosuppressants in trial

Elizabeth Warren probes abortion access

Medicare proceeds with plan to claw back hospital funds

explore

focus

explore

knowledge